top of page

Post ASH 2024 Updates w/ Dr. Ibrahim Ibrahim, MD, Dr. Yu-Min Shen, MD, and Dr. Taha Bat, MD

Fri, Feb 07

|

Online Seminar

Post ASH 2024 Updates w/ Dr. Ibrahim Ibrahim, MD, Dr. Yu-Min Shen, MD, and Dr. Taha Bat, MD
Post ASH 2024 Updates w/ Dr. Ibrahim Ibrahim, MD, Dr. Yu-Min Shen, MD, and Dr. Taha Bat, MD

Time & Location

Feb 07, 2025, 7:30 AM – 8:30 AM CST

Online Seminar

Guests

About the event

Dr. Ibrahim Ibrahim, MD, is an Associate Professor of Internal Medicine at UT Southwestern and a distinguished faculty member in the Division of Hematology and Oncology. His clinical interests encompass thrombosis, hemostasis, and thrombocytopenic disorders. Dr. Ibrahim’s recieved his medical degree at UT Southwestern, where he also completed his internal medicine residency and fellowship training in hematology and oncology.

Before joining the UT Southwestern faculty in 2018, Dr. Ibrahim served as an Assistant Professor of Internal Medicine at Houston Methodist Hospital in the Texas Medical Center. His dedication to the field is reflected in his certification by the American Board of Internal Medicine in Internal Medicine, Hematology, and Medical Oncology.

Dr. Ibrahim’s research focuses on blood disorders, resulting in multiple peer-reviewed publications and two book chapters. He has presented his findings at numerous professional and scientific conferences, contributing to the advancement of knowledge in his field.

At UT Southwestern, Dr. Ibrahim holds several key positions. He is the director of the Non-Malignant Hematology Program and serves as the medical director of both the Blood Disorders Clinic at UT Southwestern and the Benign Hematology Clinic at Parkland Hospital. His leadership extends to committee service, where he chairs the Anticoagulation Subcommittee of UT Southwestern’s Pharmacy & Therapeutic Committee and serves on the Data and Safety Monitoring Committee of the Harold C. Simmons Comprehensive Cancer Center.

Dr. Ibrahim is actively involved in several professional organizations, including the American Society of Hematology and the International Society on Thrombosis and Haemostasis. His contributions to both clinical practice and research continue to impact the field of hematology positively, making him a respected and influential figure in his specialty.

Dr. Yu-Min Shen, MD, is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center, recognized as the regional expert in coagulation disorders. As a specialist in nonmalignant hematologic disorders, Dr. Shen's areas of clinical expertise include bleeding and clotting disorders, hemostasis, and thrombosis. His distinguished career is marked by his certification from the American Board of Internal Medicine in internal medicine, hematology, and oncology.

 A Fellow of the American College of Physicians, he joined the UT Southwestern faculty in 2004. His excellence in education was honored with UT Southwestern’s 2011 Eugene P. Frenkel Outstanding Teacher of the Year Award, highlighting his commitment to teaching and mentoring the next generation of medical professionals.

In addition to his teaching accolades, Dr. Shen has delivered numerous invited lectures on international, national, and regional stages. His scholarly contributions include over 20 published articles, chapters, reviews, and case reports. He also serves as an ad hoc reviewer for the Journal of Clinical Oncology, contributing to the advancement of medical knowledge in his field.

Dr. Shen is an active member of several professional organizations, including the American Society of Hematology, the International Society on Thrombosis and Haemostasis, and the Hemophilia and Thrombosis Research Society. His educational journey began at the University of California, San Diego School of Medicine, where he earned his medical degree. He then completed both his internal medicine residency and hematology/oncology fellowship at UT Southwestern, further solidifying his expertise and dedication to patient care and medical education.

Dr. Taha Bat, MD, is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a distinguished member of its Division of Hematology and Oncology. He specializes in bone marrow failure syndromes, porphyria, paroxysmal nocturnal hemoglobinuria (PNH), pure red cell aplasia (PRCA), aplastic anemia, and large granular lymphocytic (LGL) leukemia.

Dr. Bat’s academic journey began in Turkey, where he earned his medical degree from Hacettepe University. He then completed a residency in internal medicine at Western Reserve Health Education. To further hone his expertise, Dr. Bat pursued advanced training in bone marrow syndromes through a fellowship at the Cleveland Clinic Foundation, followed by a fellowship in hematology and oncology at the University at Buffalo/Roswell Park Comprehensive Cancer Center.

Since joining the UT Southwestern faculty in 2020, Dr. Bat has focused his research on cytopenia, hemostasis, and thrombocytopenia. His scholarly work has been widely published in peer-reviewed journals, reflecting his dedication to advancing the understanding and treatment of hematologic conditions. His clinical focus areas include Bone Marrow Failure Syndromes, Clonal Hematopoiesis, Platelet Disorders, and Cancer-Related Venous Thromboembolism (VTE).

In addition to his academic and clinical roles, Dr. Bat is the founder of BMFCases, an educational platform dedicated to the study and management of bone marrow failure syndromes. Through BMFCases, he has actively championed awareness of bone marrow disorders.

Dr. Bat is also a passionate advocate for raising awareness of bone marrow disorders on both national and international stages. His commitment to the field extends to his active involvement with the American Society of Hematology, where he contributes to the ongoing education and development of hematology practices.

Share this event

bottom of page